Novel, non-invasive imaging approach to identify patients with advanced non-small cell lung cancer at risk of hyperprogressive disease with immune checkpoint blockade
Pranjal Vaidya(Case Western Reserve University), Anant Madabhushi(Emory University), Pradnya D. Patil(Cleveland Clinic), Mohammadhadi Khorrami(Case Western Reserve University), Amit Gupta(University of Washington), Prantesh Jain(Roswell Park Comprehensive Cancer Center), Vamsidhar Velcheti(Cleveland Clinic), Kaustav Bera(University Hospitals of Cleveland), Mehdi Alilou(Case Western Reserve University)
Cited by 121
Related Papers
Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation
|New England Journal of Medicine|2021|1.8k
Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2020|835
Predicting cancer outcomes with radiomics and artificial intelligence in radiology
|Nature Reviews Clinical Oncology|2021|810
Programmed death ligand-1 expression in non-small cell lung cancer
|Laboratory Investigation|2013|753
Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|416